MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Generalized choreodystonia in a patient with HIV and hepatitis C with the history of opioid drug abuse after treating with interferon- 2alpha (Peginton)

    D. Khasanova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: We reported a case of a patient G., 47 years old treated with Pegintron (1,5 mcg/kg/week) and ribavirin (15 mg/kg/day) within a year due…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Psychogenic abdominal myoclonus in Pregnancy: Case Report

    D. García, P.O. Vargaz, Z. Lopez (Toluca de Lerdo, Mexico)

    Objective: Movement disorders in pregnancy represent a diagnostic challenge due to the poor physiopathological understanding in the extrapyramidal system where the afferent and efferent circuits…
  • 2017 International Congress

    Specific Metabolic Brain Networks Associated with Parkinsonian and Cerebellar Variants of Multiple System Atrophy

    P. Wu, S. Peng, J. Wang, J. Wu, C. Jiang, J. Ge, D. Eidelberg, Y. Ma, C. Zuo (Shanghai, China)

    Objective: To identify specific metabolic brain networks for parkinsonian (MSA-P) and cerebellar (MSA-C) variants of MSA. Background: MSA is associated with a disease-related metabolic brain network (MSARP)…
  • 2017 International Congress

    Holmes’ tremor and olivary hypertrophy: lessons from this neuroanatomical correlation

    R. Ellis, S. Biswas, R. Pullicino, J. Panicker, B. Hammersley, J. Farah, S. Alusi (Liverpool, United Kingdom)

    Objective: To describe the neuroanatomical correlations of unilateral versus bilateral hypertrophic olivary degeneration (HOD) in three patients diagnosed with Holmes’ (rubral) tremor, secondary to midbrain…
  • 2017 International Congress

    Serum vitamin B12 levels in patients with Parkinson’s disease and its association with peripheral neuropathy and cognition

    R. Kandadai, N. Mathukumali, S.S. Meka, S. Tandra, A. Kohat, M. Kanikannan, R. Borgohain (Hyd, India)

    Objective: To compare serum Vitamin B12 levels among PD patients and normal controls and to assess the association of Vitamin B12 levels with various disease parameters, peripheral…
  • 2017 International Congress

    Voice Cepstral Analysis in Adductor-Type Spasmodic Dysphonia

    L. Marsili, A. Suppa, G. Costantini, G. Saggio, D. Casali, G. Delgado, G. Ruoppolo, A. Berardelli (Rome, Italy)

    Objective: To investigate differences in voice parameters between patients affected by adductor-type spasmodic dysphonia (ASD) and Healthy subjects (HS). Background: Adductor-type spasmodic dysphonia (ASD) is…
  • 2017 International Congress

    Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.

    M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)

    Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…
  • 2017 International Congress

    Domain-specific impact of cerebral white matter hyperintensities on Parkinson’s disease cognitive functioning

    P. Linortner, S. Chernavsky, T. Hendershott, K. Poston (Palo Alto, CA, USA)

    Objective: In this study, we investigate the relationship between white matter hyperintensities (WMH) and Parkinson's disease (PD) cognitive impairment using a comprehensive neuropsychological battery with…
  • 2017 International Congress

    Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson’s disease

    J.Y. Hong, Y. Lee, M. Sunwoo, Y. Sohn, P.H. Lee (Wonju, Republic of Korea)

    Objective: We investigated whether subjective cognitive decline (SCD) can reflect recent cognitive change in patients with Parkinson’s disease (PD) who had shown non-demented cognitive performance…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley